Plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura, Lancet, vol.2, p.975, 1973. ,
Serum-complement levels in haemolyticuraemic syndrome, Lancet, vol.2, pp.1505-1506, 1973. ,
Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome, Nephron, vol.62, pp.296-299, 1992. ,
Hemolytic uraemic syndrome, Lancet, vol.390, pp.681-696, 2017. ,
Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness, Am J Kidney Dis, vol.20, pp.487-490, 2008. ,
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, pp.1844-1859, 2010. ,
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations, Am J Transplant, vol.13, pp.2201-2206, 2013. ,
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome, J Am Soc Nephrol, vol.18, pp.2392-2400, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00409786
Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities, BMC Pediatr, vol.14, 2014. ,
CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS), Pediatr Nephrol, vol.31, pp.157-161, 2016. ,
A De novo deletion in the regulators of complement activation cluster producing a hybrid complement factor H/Complement Factor H-Related 3 gene in atypical hemolytic uremic syndrome, J Am Soc Nephrol, vol.27, pp.1617-1624, 2016. ,
Rare genetic variants in Shiga toxin-associated hemolytic uraemic syndrome: genetic analysis prior to transplantation is essential, Clin Kidney J, vol.10, pp.490-493, 2017. ,
Epidemiology of hemolytic uremic syndrome in children. Data from the North Italian HUS network, Eur J Pediatr, vol.175, pp.465-473, 2016. ,
Genomes Project Consortium, A global reference for human genetic variation, Nature, vol.526, issue.7571, pp.68-74, 1000. ,
Ferret: a user-friendly Java tool to extract data from the 1000 Genomes Project, Bioinformatics, vol.32, issue.14, pp.2224-2230, 2016. ,
, , p.18
,
, Exome Aggregation Consortium
, Exome aggregation consortium analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.536, pp.285-291, 2016.
ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-429, 2015. ,
, Conference Participants. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference, vol.91, pp.539-551, 2017.
Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011. ,
Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients, Mol Immunol, vol.65, pp.367-376, 2015. ,
Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.345-357, 2009. ,
,
, European Working Party on the Genetics of HUS. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome, J Am Soc Nephrol, vol.19, pp.639-646, 2008.
Atypical HUS database Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy, J Immunol, vol.200, pp.2464-2478, 2018. ,
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-4952, 2008. ,
Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis, Nephrol Dial Transplant, vol.26, pp.3399-3403, 2011. ,
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation, Mol Immunol, vol.44, pp.1835-1844, 2007. ,
Eculizumab in an anephric patient with atypical hemolytic uraemic syndrome and advanced vascular lesions, Nephrol Dial Transplant, vol.28, pp.2899-2907, 2013. ,
Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome, Am J Hum Genet, vol.68, pp.478-484, 2001. ,
Fremeaux-Bacchi V. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome, Blood, vol.125, pp.2359-2369, 2015. ,
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae, Clin Infect Dis, vol.54, pp.1413-1421, 2012. ,
Long-term outcomes of Shiga toxin hemolytic uremic syndrome, Pediatr Nephrol, vol.28, pp.2097-2105, 2013. ,
Pathogenic role of inflammatory response during Shiga toxinassociated hemolytic uremic syndrome (HUS), Pediatr Nephrol, vol.33, pp.2057-2071, 2018. ,
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells, Infect Immun, vol.81, pp.2678-2685, 2013. ,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-562, 2013. ,